Phase
Condition
Asthma
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years at the time of inclusion;
Signed and dated written informed consent in accordance with ICH GCP and local lawprior to inclusion in the study;
Patients with diagnosis of uncontrolled SA (Asthma Control Questionnaire-5 (ACQ-5)score > 1,5) established no less than 52 weeks prior to inclusion; Severe asthma isdefined as asthma, that is controlled due to treatment with ICS in medium or highdoses plus LABA and/or ALP, and/or LAMA, and/or systemic corticosteroids (sCS),and/or immunobiological therapy, while attempts to reduce the volume of therapy leadto a loss of symptom control, or asthma remains uncontrolled despite this treatment.Such therapy should be carried out at least 3 months before inclusion. Uncontrolled asthma is defined as ACQ-5>1.5.
Patients with the availability of at least 52 weeks of follow-up data (prior toinclusion) in the medical records.
Exclusion
Exclusion Criteria:
Patients receiving any biological therapy currently or within 52 weeks prior toinclusion;
Presence of chronic obstructive pulmonary disease (COPD) or idiopathic pulmonaryfibrosis (ILF) currently or in the anamnesis;
The participation in any clinical study currently or within 52 weeks prior toinclusion;
An acute or chronic disease that, as deemed by Investigator, limits the ability ofpatients to participate in this study or could influence the interpretation of theresults.
Study Design
Study Description
Connect with a study center
Research Site
Astrakhan,
Russian FederationActive - Recruiting
Research Site
Barnaul,
Russian FederationActive - Recruiting
Research Site
Blagoveshchensk,
Russian FederationActive - Recruiting
Research Site
Bryansk,
Russian FederationActive - Recruiting
Research Site
Chelyabinsk,
Russian FederationActive - Recruiting
Research Site
Ekaterinburg,
Russian FederationActive - Recruiting
Research Site
Irkutsk,
Russian FederationActive - Recruiting
Research Site
Kazan,
Russian FederationActive - Recruiting
Research Site
Khabarovsk,
Russian FederationActive - Recruiting
Research Site
Krasnodar,
Russian FederationActive - Recruiting
Research Site
Krasnoyarsk,
Russian FederationActive - Recruiting
Research Site
Moscow,
Russian FederationActive - Recruiting
Research Site
Murmansk,
Russian FederationActive - Recruiting
Research Site
Nalchik,
Russian FederationActive - Recruiting
Research Site
Nizhniy Novgorod,
Russian FederationActive - Recruiting
Research Site
Nizhny Novgorod,
Russian FederationActive - Recruiting
Research Site
Novosibirsk,
Russian FederationActive - Recruiting
Research Site
Omsk,
Russian FederationActive - Recruiting
Research Site
Orenburg,
Russian FederationActive - Recruiting
Research Site
Petrozavodsk,
Russian FederationActive - Recruiting
Research Site
Ryazan,
Russian FederationActive - Recruiting
Research Site
Saint Petersburg,
Russian FederationSite Not Available
Research Site
Saint-Petersburg,
Russian FederationActive - Recruiting
Research Site
Samara,
Russian FederationActive - Recruiting
Research Site
Saratov,
Russian FederationActive - Recruiting
Research Site
Smolensk,
Russian FederationActive - Recruiting
Research Site
Stavropol,
Russian FederationActive - Recruiting
Research Site
Tomsk,
Russian FederationActive - Recruiting
Research Site
Ufa,
Russian FederationActive - Recruiting
Research Site
Ulan Ude,
Russian FederationSite Not Available
Research Site
Ulan-Ude,
Russian FederationActive - Recruiting
Research Site
Verkhnyaya Pyshma,
Russian FederationActive - Recruiting
Research Site
Vladimir,
Russian FederationActive - Recruiting
Research Site
Vladivostok,
Russian FederationActive - Recruiting
Research Site
Volgograd,
Russian FederationActive - Recruiting
Research Site
Voronezh,
Russian FederationActive - Recruiting
Research Site
Yekaterinburg,
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.